EUVIMEDEUVIMED entdecken
Open Access

Linking Lipidomics to Vulnerable Coronary Plaques: A PROSPECT II Substudy

Tania Sharma iD, Tove Fall iD, Sergi Sayols-Baixeras, Akiko Maehara iD, Michael Maeng iD, Lars Kjøller-Hansen iD, Thomas Engstrøm iD, Ori Ben-Yehuda iD, Mitsuaki Matsumura iD, Ole Fröbert iD, Jonas Persson iD, Rune Wiseth iD und 13 weitere

Arteriosclerosis, Thrombosis, and Vascular Biology · 2026-08 · 46 (8)

DOI: 10.1161/atvbaha.125.324430 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2026-08. Verfasst von Tania Sharma und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Clinical Sciences (T.S., J.G.S., S.K., R.R., D.E.), Lund University, Lund, Sweden. Hauptthemen laut MEDLINE: Plaque, Atherosclerotic, Coronary Artery Disease, Lipidomics, Coronary Vessels. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Lipidomics, the comprehensive profiling of circulating lipid species, has emerged as a powerful tool to investigate metabolic alterations underlying coronary atherosclerosis. Understanding the mechanisms driving high-risk vulnerable plaque formation and progression to myocardial infarction remains a key therapeutic priority. This study investigates associations between circulating lipid metabolites and imaging-defined features of vulnerable coronary plaque. METHODS: Following revascularization, patients with myocardial infarction underwent 3-vessel coronary artery imaging with near-infrared spectroscopy and intravascular ultrasound to assess nonflow-limiting plaques for lipid core burden index and plaque burden. Multivariable models evaluated associations between 424 lipid metabolites in plasma, quantified by mass spectrometry, pan-coronary lipid, pan-coronary plaque burden, and high-risk vulnerable plaque measures (maximum lipid core burden index within any 4-mm segment across the entire lesion ≥324.7 and/or plaque burden ≥70%) in 877 patients. Findings were validated in the SCAPIS study (Swedish Cardiopulmonary Bioimage Study) using coronary computed tomography angiography–based measures of coronary artery calcium score and segment involvement score. RESULTS: We identified 156 significant associations ( P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plaque, AtheroscleroticCoronary Artery DiseaseLipidomicsCoronary VesselsLipidsHumansUltrasonography, InterventionalFemaleMaleMiddle AgedAgedCoronary AngiographySpectroscopy, Near-InfraredRupture, SpontaneousSphingomyelinsPredictive Value of TestsComputed Tomography AngiographyMyocardial InfarctionBiomarkersRisk FactorsProspective Studies

Stichwörter der Autor:innen

atherosclerosiscoronary plaque vulnerabilityischaemic heart diseaselipidomicspercutaneous coronary interventionsphingomyelin

Substanzen

SphingomyelinsLipidsBiomarkers

Autor:innen und Institutionen

  • Department of Cardiology, Clinical Sciences (T.S., J.G.S., S.K., R.R., D.E.), Lund University, Lund, Sweden.
  • National Heart and Lung Institute, Imperial College London, United Kingdom (T.S., R.Y.K.).
  • Molecular Epidemiology, Department of Medical Sciences (T.F., S.S.-B.), Uppsala University, Sweden.
  • Medical Epidemiology, Department of Surgical Sciences (S.S.-B.), Uppsala University, Sweden.
  • CIBER Cardiovascular Diseases (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain (S.S.-B.).
  • New York-Presbyterian Hospital and Columbia University Irving Medical Center (A.M.).

ORCID-Profile: Tania Sharma, Tove Fall, Akiko Maehara, Michael Maeng, Lars Kjøller-Hansen, Thomas Engstrøm, Ori Ben-Yehuda, Mitsuaki Matsumura, Ole Fröbert, Jonas Persson, Rune Wiseth, Alf Inge Larsen, J Gustav Smith, Gunnar Engström, Johan Ärnlöv, Jan Borén, Ramzi Y Khamis, Sotirios Tsimikas, Rebecca Rylance, Ziad A Ali, Stefan K James, Gregg W Stone, David Erlinge

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Sharma, T., Fall, T., Sayols-Baixeras, S., Maehara, A., Maeng, M., Kjøller-Hansen, L., Engstrøm, T., Ben-Yehuda, O., Matsumura, M., Fröbert, O., Persson, J., Wiseth, R., Larsen, A. I., Smith, J. G., Engström, G., Ärnlöv, J., Borén, J., Khamis, R. Y., Tsimikas, S., …, & Erlinge, D. (2026). Linking Lipidomics to Vulnerable Coronary Plaques: A PROSPECT II Substudy. Arteriosclerosis, Thrombosis, and Vascular Biology, 46(8). https://doi.org/10.1161/atvbaha.125.324430

Vancouver

Sharma T, Fall T, Sayols-Baixeras S, Maehara A, Maeng M, Kjøller-Hansen L, et al. Linking Lipidomics to Vulnerable Coronary Plaques: A PROSPECT II Substudy. Arteriosclerosis, Thrombosis, and Vascular Biology. 2026;46(8). doi:10.1161/atvbaha.125.324430

BibTeX
@article{Sharma2026,
  author = {Sharma, Tania and Fall, Tove and Sayols-Baixeras, Sergi and Maehara, Akiko and Maeng, Michael and Kjøller-Hansen, Lars and Engstrøm, Thomas and Ben-Yehuda, Ori and Matsumura, Mitsuaki and Fröbert, Ole and Persson, Jonas and Wiseth, Rune and Larsen, Alf Inge and Smith, J Gustav and Engström, Gunnar and Ärnlöv, Johan and Borén, Jan and Khamis, Ramzi Y and Tsimikas, Sotirios and Koul, Sasha and Rylance, Rebecca and Ali, Ziad A and James, Stefan K and Stone, Gregg W and Erlinge, David},
  title = {Linking Lipidomics to Vulnerable Coronary Plaques: A PROSPECT II Substudy},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2026},
  volume = {46},
  number = {8},
  doi = {10.1161/atvbaha.125.324430}
}
Kostenlos starten →